Personal monitoring of symptoms and medication adherence in atrial fibrillation (review)
https://doi.org/10.15829/1560-4071-2025-6772
EDN: FECJKJ
Abstract
Due to the high prevalence of atrial fibrillation (AF), including subclinical forms, the search for novel approaches to screening for this arrhythmia, monitoring symptoms, and effective methods for monitoring therapy adherence is becoming increasingly important. Along with implantable monitors, modern digital methods for personalized rhythm monitoring are being used to diagnose AF: wireless recorders, smart devices, mobile assistants, and other technologies. This paper provides a comparative analysis of the most common personal monitoring methods for AF, developed to assess disease progression, manage symptoms, and prevent complications. Modern technologies for improving medication adherence in various clinical patient groups are also discussed. The authors present results on the development of original mobile application for patients with AF.
About the Authors
S. V. Garkina
Almazov National Medical Research Center
Russian Federation
Russian Federation
Akkuratova str., 2, St. Petersburg, 197341
V. S. Orshanskaya
Almazov National Medical Research Center
Russian Federation
Russian Federation
Akkuratova str., 2, St. Petersburg, 197341
A. D. Lebedev
Almazov National Medical Research Center
Russian Federation
Russian Federation
Akkuratova str., 2, St. Petersburg, 197341
D. S. Lebedev
Almazov National Medical Research Center
Russian Federation
Russian Federation
Akkuratova str., 2, St. Petersburg, 197341
References
1. Sharma A, Harrington RA, McClellan MB. Using Digital Health Technology to Better Generate Evidence and Deliver Evidence-Based Care. JACC. 2018;71(23):2680-90. doi:10.1016/j.jacc.2018.03.523.
2. Istepanian RSH. Mobile Health (m-Health) in Retrospect: The Known Unknowns. Int J Environ Res Public Health. 2022;19(7):3747. doi:10.3390/ijerph19073747.
3. January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2019;74(1):104-32.
4. Miyazawa K, Ogawa H, Mazurek M, et al. Guideline-adherent treatment for stroke and death in atrial fibrillation patients from UK and Japanese AF registries. Circ J. 2019;83:2434-42.
5. Lane DA, Meyerhoff J, Rohner U, et al. Atrial fibrillation patient preferences for oral anticoagulation and stroke knowledge: results of a conjoint analysis. Clin Cardiol. 2018;41:855-61.
6. Efimova OI, Sergeeva MA, Pavlova TV, et al. Patient with cardioembolic stroke: clinical characteristics and typical features. Fundamental and Clinical Medicine. 2020;5(2):30-8. (In Russ.) doi:10.23946/2500-0764-2020-5-2-30-38.
7. Botto GL, Padeletti L, Santini M, et al. Presence and Duration of Atrial Fibrillation Detected by Continuous Monitoring: Crucial Implications for the Risk of Thromboembolic Events. Journal of Cardiovascular Electrophysiology. 2009;20:241-8. doi:10.1111/j.1540-8167.2008.01320.x.
8. Arnar DO, Mairesse GH, Boriani G, et al.; ESC Scientific Document Group; EHRA Scientific Documents Committee. Management of asymptomatic arrhythmias: a European Heart Rhythm Association (EHRA) consensus document, endorsed by the Heart Failure Association (HFA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin America Heart Rhythm Society (LAHRS). Europace. 2019;21(6):844-5. doi:10.1093/europace/euz046.
9. Ciconte G, Giacopelli D, Pappone C. The Role of Implantable Cardiac Monitors in Atrial Fibrillation Management. J Atr Fibrillation. 2017;10(2):1590. doi:10.4022/jafib.1590.
10. Potpara TS, Polovina MM, Marinkovic JM, et al. A comparison of clinical characteristics and long-term prognosis in asymptomatic and symptomatic patients with first-diagnosed atrial fibrillation: the Belgrade Atrial Fibrillation Study. Int J Cardiol. 2013;168:4744-9.
11. Engdahl J, Holmen A, Rosenqvist M, et al. A prospective 5 year follow-up after populationbased systematic screening for atrial fibrillation. Europace. 2018;20:f306-11.
12. Benezet-Mazuecos J, Rubio JM, Farré J. Atrial high rate episodes in patients with dualchamber cardiac implantable electronic devices: unmasking silent atrial fibrillation. Pacing Clin Electrophysiol. 2014;37:1080-6. doi:10.1111/pace.12428.
13. Glotzer TV, Daoud EG, Wyse DG, et al. The relationship between daily atrial tachyarrhytmia burden from implantable device diagnostics and stroke risk: the TRENDS study. Circ Arrhythm Electrophysiol. 2009;2:474-80. doi:10.1161/CIRCEP.109.849638.
14. Healey JS, Connolly SJ, Gold MR, et al. Subclinical Atrial Fibrillation and the Risk of Stroke. N Engl J Med. 2012;366:120-9. doi:10.1056/NEJMoa1105575.
15. Glotzer TV, Ziegler PD. Cryptogenic stroke: Is silent atrial fibrillation the culprit? Heart Rhythm. 2015;12:234-41. doi:10.1016/j.hrthm.2014.09.058.
16. Mairesse GH, Moran P, Van Gelder IC, et al. Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE). Europace. 2017;19:1589-623.
17. Van Gelder IC, Rienstra M, Bunting KV, et al. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for CardioThoracic Surgery (EACTS): Developed by the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC), with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Endorsed by the European Stroke Organisation (ESO). Eur Heart J. 2024;45(36):3314-414. doi:10.1093/eurheartj/ehae176.
18. Kalarus Z, Mairesse GH, Sokal A, et al. Searching for atrial fibrillation: looking harder, looking longer, and in increasingly sophisticated ways. An EHRA position paper. Europace. 2023;25(1):185-98. doi:10.1093/europace/euac144. Erratum in: Europace. 2024;26(6):euae167. doi:10.1093/europace/euae167.
19. Bumgarner JM, Lambert CT, Hussein AA, et al. Smartwatch Algorithm for Automated Detection of Atrial Fibrillation. J Am Coll Cardiol. 2018;71:2381-8. doi:10.1016/j.jacc.2018.03.003.
20. Khalikova MA, Tsaregorodtsev DA, Beraya MM, et al. Advantages of using a portable cardiac monitor in outpatients with paroxysmal atrial fibrillation. Cardiovascular Therapy and Prevention. 2022;21(6):3225. (In Russ.) doi:10.15829/1728-8800-2022-3225. EDN: OCUZAP
21. Kuznetsova NO, Nartova AA, Kurbanalieva NK, et al. The results of screening of cardiac arrhythmias using a single-channel electrocardiogram without the participation of medical personnel. Bulletin of New Medical Technologies. 2025;(1):56-60. (In Russ.):10.24412/1609-2163-2025-1-56-60. EDN: YWJLFH.
22. Berdnikov SV, Berdnikova OA. Perspective technologies for screening heart rhythm disturbances: focus on mobile ECG devices. Russian Journal of Cardiology. 2018;(12):92-7. (In Russ.) doi:10.15829/1560-4071-2018-12-92-97.
23. Mesitskaya DF, Fashafsha ZZA, Poltavskaya MG, et al. A single-lead ECG based cardiotoxicity detection in patients on polychemotherapy. Int J Cardiol Heart Vasc. 2024;50: 101336. doi:10.1016/j.ijcha.2024.101336.
24. Kuznetsova N, Gubina A, Sagirova Z, et al. Left Ventricular Diastolic Dysfunction Screening by a Smartphone-Case Based on Single Lead ECG. Clin Med Insights Cardiol. 2022;16:11795468221120088. doi:10.1177/11795468221120088.
25. Kobyakova OS, Starodubov VI, Kurakova NG, Tsvetkova LA. Digital Twins in Healthcare: an Assessment of Technological and Practical Prospects. Annals of the Russian academy of medical sciences. 2021;76(5):476-87. (In Russ.) doi:10.15690/vramn1717.
26. Belenkov YuN, Kozhevnikova MV. Mobile healthcare technologies in cardiology. Kardiologiia. 2022;62(1):4-12. (In Russ.)
27. Conn VS, Hafdahl AR, Cooper PS, et al. Interventions to Improve Medication Adherence Among Older Adults: Meta-Analysis of Adherence Outcomes Among Randomized Controlled Trials. Gerontologist. 2009;49(4):447-62.
28. Efremova E, Shutov A. Adherence to Lifestyle Therapy in Patients with Chronic Heart Failure and Comorbidity. International Cardiovascular Forum Journal. 2019;16:32-7. doi:10.17987/icfj.v16i0.574.
29. Russell CL, Ruppar TM, Matteson M. Improving medication adherence: moving from intention and motivation to a personal systems approach. Nurs Clin North Am. 2011;46(3):271-81. doi:10.1016/j.cnur.2011.05.004.
30. Dolginina SI, Garkina SV, Khokhlunov SM, Lebedev DS. Modeling the prognosis of patients after interventional treatment of atrial fibrillation, taking into account possible predictors of arrhythmia recurrence. Translational Medicine. 2016;3(2):17-22. (In Russ.)
31. Pomerantz JM. Improving medication adherence: A new marketing opportunity for the pharmaceutical industry. Drug Benefit Trends. 2004;16:279-80.
32. Bartlett JD, Voce M, Than TP. Electronic Monitoring System to Assess Patient Adherence in Pediatric Drug Studies. Investigative Ophthalmology & Visual Science. 2003;44(13):19-30.
33. Mohamed Abd-Elfattah SA. Improving healthcare using Smart Pill Box for Medicine Reminder and Monitoring System. Future Computing and Informatics Journal Smart drugs. 2018;3(2):443-56.
34. Parker CS, Chen Z, Price M, et al. Adherence to Warfarin Assessed by Electronic Pill Caps, Clinician Assessment, and Patient Reports: Results From the IN-RANGE Study. J Gen Intern Med. 2007;22(9):1254-9. doi:10.1007/s11606-007-0233-1.
35. Checchi KD, Huybrechts KF, Avorn J. Electronic medication packaging devices and medication adherence: A systematic review. JAMA. 2014;312(12):1237-47. doi:10.1001/jama.2014.10059.
36. Hagstrom B, Mattsson B, Rost IM, et al. What happened to the prescriptions? A single, short, standardized telephone call may increase compliance. FamPract. 2004;21(1):46-50.
37. Guo Y, Lane DA, Wang L, et al. Mobile Health Technology to Improve Care for Patients With Atrial Fibrillation. J Am Coll Cardiol. 2020;75:1523-34.
Review
For citations:
Garkina S.V., Orshanskaya V.S., Lebedev A.D., Lebedev D.S. Personal monitoring of symptoms and medication adherence in atrial fibrillation (review). Russian Journal of Cardiology. 2025;30(4S):6772. (In Russ.) https://doi.org/10.15829/1560-4071-2025-6772. EDN: FECJKJ
Views:
217
JATS XML
Email this article 